Want to see JP:6823 full AI Analyst Report?
Rion Co., Ltd. (6823) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pep-Tisseel, Tisseel Fibrin Sealant Kit | Chronic Radiation Ulcer | phase1AndPhase2 | Not Yet Recruiting | Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer | Jan 16, 2025 | ― |
| Pep (Purified Exosome Product) / Tisseel | Diabetic Foot Ulcer | Phase II | Active Not Recruiting | Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) | Mar 13, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pep-Tisseel, Tisseel Fibrin Sealant Kit | phase1AndPhase2 | Chronic Radiation Ulcer | Not Yet Recruiting | Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer | Jan 16, 2025 | ― |
| Pep (Purified Exosome Product) / Tisseel | Phase II | Diabetic Foot Ulcer | Active Not Recruiting | Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) | Mar 13, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Rion Co., Ltd. (JP:6823) have in its pipeline
Rion Co., Ltd. JP:6823 is currently developing the following drugs: Pep-Tisseel, Tisseel Fibrin Sealant Kit, Pep (Purified Exosome Product) / Tisseel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
